Literature DB >> 24076983

Incontinence in individuals with Angelman syndrome: a comparative study.

Maartje Radstaake1, Robert Didden, Sanne Giesbers, Hubert Korzilius, Nienke Peters-Scheffer, Russell Lang, Alexander von Gontard, Leopold M G Curfs.   

Abstract

Frequency and type of incontinence and variables associated with incontinence were assessed in individuals with Angelman syndrome (AS; n=71) and in a matched control group (n=69) consisting of individuals with non-specific intellectual disability (ID). A Dutch version of the "Parental Questionnaire: Enuresis/Urinary Incontinence" (Beetz, von Gontard, & Lettgen, 1994) was administered and information on primary caretakers' perspectives regarding each individual's incontinence was gathered. Results show that diurnal incontinence and fecal incontinence during the day more frequently occurred in the control group than in the AS group. In both groups, nocturnal enuresis was the most common form of incontinence. More incontinence was seen in individuals with AS who were younger, had a lower level of adaptive functioning and/or had epilepsy. Individuals with AS were able to stay dry for longer periods of time than the controls and often showed both in-toilet urination and urinary accidents during the day, whereas accidents and correct voids during the day were more set apart in the control group. Also, persons with AS had a lower micturition frequency implying possible voiding postponement. Both groups showed high rates of LUTS (lower urinary tract symptoms) possibly indicative of functional bladder disorders such as voiding postponement, dysfunctional voiding, or even an underactive bladder. In general, most primary caretakers reported severe intellectual disability as the main cause for urinary incontinence. Based on these results incontinence does not appear to be part of the behavioral phenotype of Angelman syndrome. Therefore, pediatric or urologic diagnostics and treatment are recommended for all persons with incontinence and intellectual disability. Further implications for practice and research are given.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angelman syndrome; Behavioral phenotype; Incontinence; Intellectual disability

Mesh:

Year:  2013        PMID: 24076983     DOI: 10.1016/j.ridd.2013.09.007

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  5 in total

1.  Incontinence in persons with Angelman syndrome.

Authors:  C Wagner; J Niemczyk; M Equit; L Curfs; A von Gontard
Journal:  Eur J Pediatr       Date:  2016-12-20       Impact factor: 3.183

2.  Developmental polychlorinated biphenyl (PCB) exposure alters voiding physiology in young adult male and female mice.

Authors:  Conner L Kennedy; Audrey Spiegelhoff; Thomas Lavery; Kathy Wang; Robbie Sj Manuel; Zunyi Wang; Hannah Wildermuth; Kimberly P Keil Stietz
Journal:  Am J Clin Exp Urol       Date:  2022-04-15

3.  Detailed assessment of incontinence in boys with fragile-X-syndrome in a home setting.

Authors:  Justine Niemczyk; Alexander von Gontard; Monika Equit; Katharina Bauer; Teresa Naumann; C Wagner; Leopold Curfs
Journal:  Eur J Pediatr       Date:  2016-08-27       Impact factor: 3.183

Review 4.  Unmet clinical needs and burden in Angelman syndrome: a review of the literature.

Authors:  Anne C Wheeler; Patricia Sacco; Raquel Cabo
Journal:  Orphanet J Rare Dis       Date:  2017-10-16       Impact factor: 4.123

Review 5.  A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome.

Authors:  Jessica Duis; Mark Nespeca; Jane Summers; Lynne Bird; Karen G C B Bindels-de Heus; M J Valstar; Marie-Claire Y de Wit; C Navis; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Susan Ernst; Melina Dendrinos; Terry Katz; Gloria Diaz-Medina; Akshat Katyayan; Srishti Nangia; Ronald Thibert; Daniel Glaze; Christopher Keary; Karine Pelc; Nicole Simon; Anjali Sadhwani; Helen Heussler; Anne Wheeler; Caroline Woeber; Margaret DeRamus; Amy Thomas; Emily Kertcher; Lauren DeValk; Kristen Kalemeris; Kara Arps; Carol Baym; Nicole Harris; John P Gorham; Brenda L Bohnsack; Reid C Chambers; Sarah Harris; Henry G Chambers; Katherine Okoniewski; Elizabeth R Jalazo; Allyson Berent; Carlos A Bacino; Charles Williams; Anne Anderson
Journal:  Mol Genet Genomic Med       Date:  2022-02-11       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.